617 related articles for article (PubMed ID: 26784651)
1. Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults.
Gold DR; Litonjua AA; Carey VJ; Manson JE; Buring JE; Lee IM; Gordon D; Walter J; Friedenberg G; Hankinson JL; Copeland T; Luttmann-Gibson H
Contemp Clin Trials; 2016 Mar; 47():185-95. PubMed ID: 26784651
[TBL] [Abstract][Full Text] [Related]
2. Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).
Bassuk SS; Manson JE; Lee IM; Cook NR; Christen WG; Bubes VY; Gordon DS; Copeland T; Friedenberg G; D'Agostino DM; Ridge CY; MacFadyen JG; Kalan K; Buring JE
Contemp Clin Trials; 2016 Mar; 47():235-43. PubMed ID: 26767629
[TBL] [Abstract][Full Text] [Related]
3. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.
Manson JE; Bassuk SS; Lee IM; Cook NR; Albert MA; Gordon D; Zaharris E; Macfadyen JG; Danielson E; Lin J; Zhang SM; Buring JE
Contemp Clin Trials; 2012 Jan; 33(1):159-71. PubMed ID: 21986389
[TBL] [Abstract][Full Text] [Related]
4. Effect of Marine Omega-3 Fatty Acid and Vitamin D Supplementation on Incident Atrial Fibrillation: A Randomized Clinical Trial.
Albert CM; Cook NR; Pester J; Moorthy MV; Ridge C; Danik JS; Gencer B; Siddiqi HK; Ng C; Gibson H; Mora S; Buring JE; Manson JE
JAMA; 2021 Mar; 325(11):1061-1073. PubMed ID: 33724323
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D and omega-3 trial to prevent and treat diabetic kidney disease: Rationale, design, and baseline characteristics.
de Boer IH; Zelnick LR; Lin J; Schaumberg D; Wang L; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
Contemp Clin Trials; 2018 Nov; 74():11-17. PubMed ID: 30282055
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vitamin D and Omega-3 Fatty Acid Supplementation on Kidney Function in Patients With Type 2 Diabetes: A Randomized Clinical Trial.
de Boer IH; Zelnick LR; Ruzinski J; Friedenberg G; Duszlak J; Bubes VY; Hoofnagle AN; Thadhani R; Glynn RJ; Buring JE; Sesso HD; Manson JE
JAMA; 2019 Nov; 322(19):1899-1909. PubMed ID: 31703120
[TBL] [Abstract][Full Text] [Related]
7. Update on the Vitamin D and OmegA-3 trial (VITAL).
Pradhan AD; Manson JE
J Steroid Biochem Mol Biol; 2016 Jan; 155(Pt B):252-6. PubMed ID: 25864623
[TBL] [Abstract][Full Text] [Related]
8. Effect of Vitamin D and ω-3 Fatty Acid Supplementation on Risk of Age-Related Macular Degeneration: An Ancillary Study of the VITAL Randomized Clinical Trial.
Christen WG; Cook NR; Manson JE; Buring JE; Chasman DI; Lee IM; Bubes V; Li C; Haubourg M; Schaumberg DA;
JAMA Ophthalmol; 2020 Dec; 138(12):1280-1289. PubMed ID: 33119047
[TBL] [Abstract][Full Text] [Related]
9. The VITamin D and OmegA-3 TriaL-Depression Endpoint Prevention (VITAL-DEP): Rationale and design of a large-scale ancillary study evaluating vitamin D and marine omega-3 fatty acid supplements for prevention of late-life depression.
Okereke OI; Reynolds CF; Mischoulon D; Chang G; Cook NR; Copeland T; Friedenberg G; Buring JE; Manson JE
Contemp Clin Trials; 2018 May; 68():133-145. PubMed ID: 29526608
[TBL] [Abstract][Full Text] [Related]
10. Effects of daily vitamin D supplementation on respiratory muscle strength and physical performance in vitamin D-deficient COPD patients: a pilot trial.
Rafiq R; Prins HJ; Boersma WG; Daniels JM; den Heijer M; Lips P; de Jongh RT
Int J Chron Obstruct Pulmon Dis; 2017; 12():2583-2592. PubMed ID: 28894361
[TBL] [Abstract][Full Text] [Related]
11. VITAL-Bone Health: rationale and design of two ancillary studies evaluating the effects of vitamin D and/or omega-3 fatty acid supplements on incident fractures and bone health outcomes in the VITamin D and OmegA-3 TriaL (VITAL).
LeBoff MS; Yue AY; Copeland T; Cook NR; Buring JE; Manson JE
Contemp Clin Trials; 2015 Mar; 41():259-68. PubMed ID: 25623291
[TBL] [Abstract][Full Text] [Related]
12. Effect of Vitamin D3 Supplements on Development of Advanced Cancer: A Secondary Analysis of the VITAL Randomized Clinical Trial.
Chandler PD; Chen WY; Ajala ON; Hazra A; Cook N; Bubes V; Lee IM; Giovannucci EL; Willett W; Buring JE; Manson JE;
JAMA Netw Open; 2020 Nov; 3(11):e2025850. PubMed ID: 33206192
[TBL] [Abstract][Full Text] [Related]
13. Effects of long-term vitamin D and n-3 fatty acid supplementation on inflammatory and cardiac biomarkers in patients with type 2 diabetes: secondary analyses from a randomised controlled trial.
Limonte CP; Zelnick LR; Ruzinski J; Hoofnagle AN; Thadhani R; Melamed ML; Lee IM; Buring JE; Sesso HD; Manson JE; de Boer IH
Diabetologia; 2021 Feb; 64(2):437-447. PubMed ID: 33098434
[TBL] [Abstract][Full Text] [Related]
14. Effect of Vitamin D3 Supplementation on Severe Asthma Exacerbations in Children With Asthma and Low Vitamin D Levels: The VDKA Randomized Clinical Trial.
Forno E; Bacharier LB; Phipatanakul W; Guilbert TW; Cabana MD; Ross K; Covar R; Gern JE; Rosser FJ; Blatter J; Durrani S; Han YY; Wisniewski SR; Celedón JC
JAMA; 2020 Aug; 324(8):752-760. PubMed ID: 32840597
[TBL] [Abstract][Full Text] [Related]
15. Effect of Vitamin D3 and Omega-3 Fatty Acid Supplementation on Risk of Frailty: An Ancillary Study of a Randomized Clinical Trial.
Orkaby AR; Dushkes R; Ward R; Djousse L; Buring JE; Lee IM; Cook NR; LeBoff MS; Okereke OI; Copeland T; Manson JE
JAMA Netw Open; 2022 Sep; 5(9):e2231206. PubMed ID: 36098968
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Marine ω-3 Fatty Acid Supplementation vs Placebo in Reducing Incidence of Dry Eye Disease in Healthy US Adults: A Randomized Clinical Trial.
Christen WG; Cook NR; Manson JE; Buring JE; Lee IM; Bubes V; Friedenberg G; Dushkes R; Smith D; Schaumberg DA;
JAMA Ophthalmol; 2022 Jul; 140(7):707-714. PubMed ID: 35679030
[TBL] [Abstract][Full Text] [Related]
17. A Randomized, Double-Blind, Placebo-Controlled Clinical Trial to Assess the Efficacy and Safety of Ethyl-Ester Omega-3 Fatty Acid in Taiwanese Hypertriglyceridemic Patients.
Su TC; Hwang JJ; Huang KC; Chiang FT; Chien KL; Wang KY; Charng MJ; Tsai WC; Lin LY; Vige R; Olivar JE; Tseng CD
J Atheroscler Thromb; 2017 Mar; 24(3):275-289. PubMed ID: 27600795
[TBL] [Abstract][Full Text] [Related]
18. The effect of vitamin D and omega-3 fatty acid supplementation on pain prevalence and severity in older adults: a large-scale ancillary study of the VITamin D and OmegA-3 triaL (VITAL).
Soens MA; Sesso HD; Manson JE; Fields KG; Buring JE; Lee IM; Cook NR; Kim E; Bubes V; Dushkes R; Serhan CN; Rathmell JP
Pain; 2024 Mar; 165(3):635-643. PubMed ID: 37878483
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.
Martineau AR; James WY; Hooper RL; Barnes NC; Jolliffe DA; Greiller CL; Islam K; McLaughlin D; Bhowmik A; Timms PM; Rajakulasingam RK; Rowe M; Venton TR; Choudhury AB; Simcock DE; Wilks M; Degun A; Sadique Z; Monteiro WR; Corrigan CJ; Hawrylowicz CM; Griffiths CJ
Lancet Respir Med; 2015 Feb; 3(2):120-130. PubMed ID: 25476069
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial.
Hahn J; Cook NR; Alexander EK; Friedman S; Walter J; Bubes V; Kotler G; Lee IM; Manson JE; Costenbader KH
BMJ; 2022 Jan; 376():e066452. PubMed ID: 35082139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
